Abstract: Remifentanil is being used increasingly as one component of total intravenous anesthesia. Severe postoperative pain has occasionally been reported with discontinuation of remifentanil. This study was designed to determine the involvement of conventional protein kinase Cgamma (cPKCg) in the inhibitory action of lidocaine on remifentanil-induced hyperalgesia of rats after propofol-remifentanil-based anesthesia. Male Sprague-Dawley rats were allocated into the following groups randomly: propofol only (P), propofol+remifentanil (R), propofol+remifentanil+lidocaine (RL), and propofol+ lidocaine (L). Cumulative pain score and withdrawal response to mechanical stimulation, immunoblotting, and immunofluorescence were applied to observe remifentanil-induced hyperalgesia and cPKCg membrane translocation. We found that the cumulative pain score of group R increased significantly at 30, 120, and 300 minutes postanesthesia (P<0.05). After plantar incision, the withdrawal threshold on both the contralateral and the ipsilaeral side at 30, 120, and 300 minutes postanesthesia in group R was significantly lower than in groups P, RL, and L (P<0.05). Both immunoblotting and immunofluorescence showed that cPKCg membrane translocation increased in dorsal horn neurons of propofol-remifentanil-based anesthetized rats, which could be inhibited by systemic lidocaine. These results suggested that increased cPKCg membrane translocation was involved in remifentanil-induced hyperalgesia, which was inhibited by systemic lidocaine and may contribute to reduced postoperative pain in rats after propofol-remifentanil-based anesthesia.
R
emifentanil is a short-acting opioid that could be used to provide adequate, titratable, and predictable analgesia throughout surgery, and to decrease the risk of opioid-related delay in postoperative recovery. Remifentanil is used as an anesthetic increasingly for neurosurgery. [1] [2] [3] [4] [5] [6] Although Lahtinen et al 7 reported remifentanil infusion does not induce opioid tolerance after cardiac surgery, major surgeries with remifentanilbased anesthesia are occasionally associated with acute opioid tolerance and postoperative hyperalgesia. [8] [9] [10] Therefore choosing an adequate combination that can bring the advantages of remifentanil into full play and prevent the severe postoperative pain has become a main concern for anesthesiologists.
Recent studies demonstrated that the mechanism of opioid-induced hyperalgesia or acute opioid tolerance worsen pain sensation and perception, especially with remifentanil. 8, 11, 12 Some antihyperalgesia drugs may attenuate postoperative pain in remifentanil-based anesthesia. Because the N-methyl-D-aspartate (NMDA) receptor plays a key role in central hyperalgesia, its antagonist, ketamine, had been used to prevent remifentanil-induced hyperalgesia clinically. 8 Experimental studies in healthy volunteers indicated that lidocaine also has suppressive effect on secondary hyperalgesia. [13] [14] [15] Further, an in vitro study showed lidocaine could inhibit the activation of human NMDA receptor in a concentration dependent manner, and may be mediated by inhibition of protein kinase C (PKC). 16 To test the clinical utility of lidocaine on analgesia, we have observed that systemic administration of low-dose lidocaine reduced morphine requirements and postoperative pain of patients undergoing thoracic surgery after propofolremifentanil-based anesthesia (unpublished).
On the basis of studies, spinal dorsal horn is one important site involved in opioid-induced hyperalgesia. [17] [18] [19] [20] Previous studies reported that PKC in spinal cord plays a critical role in hyperalgesia. [21] [22] [23] Among PKC isozymes, the gamma isozyme of conventional PKC (cPKCg) is exclusively found in a small population of interneurons in the lamina II (substantia gelatinosa) inner portion of the superficial dorsal horn of spinal cord. 24, 25 In addition, it has been suggested that PKC functionally potentiates NMDA-induced currents in isolated trigeminal neurons via alleviation of the NMDA receptor voltage-dependent Mg 2+ block. 26 Therefore, the objective of this study was to determine the involvement of cPKCg in the inhibitory action of lidocaine on remifentanil-induced hyperalgesia in rats after propofol-remifentanil-based anesthesia by using the technique of PKC membrane translocation, a recognized indicator of PKC activation. 27, 28 
MATERIALS AND METHODS
Experiments were carried out on male SpragueDawley rats at the age of 8 to 10 weeks and weighing 240 to 260 g. The animal protocol was approved by Institutional Animal Care and Use Committee of Capital Medical University and is consistent with the ethical guidelines of the International Association for the Study of Pain for pain research in conscious animals. 29 A total of 312 rats were assigned into 9 groups including control (rats without any treatment, n = 24), sham (4 anesthesia groups without operation, n = 152), and operation groups (4 anesthesia groups with right hind paw incision, n = 136).
Anesthesia Protocol
Rats were restrained in a plastic bottle to establish intravenous access via tail vein by a 24G trocar. Two hundred eighty-eight rats were allocated into the following groups randomly: propofol only (P, n = 72), propofol+remifentanil (R, n = 72), propofol+remifentanil+ lidocaine (RL, n = 72), and propofol+lidocaine (L, n = 72). After successful cannulation, infusion pumps were connected for intravenous anesthesia and the anesthetic protocol was followed as outlined in Table 1 . Dosages of anesthetic agents in 4 groups (250 g rat) are shown in Table 2 . The anesthetic level was monitored by checking righting reflex, pinch withdrawal reflex, eyelid reflex, and the vibrissae spontaneous rapid whisking. All rats breathed spontaneously at a rate about 60 breathes/ min, and a sufficient depth of anesthesia was maintained such that all above-mentioned reflexes were absent and no spontaneous whisking tremors. 30 The drugs were purchased from the indicated companies as follows: propofol (AstraZeneca S.p.A., Italy), remifentanil (Yichang Humanwell Pharmaceutical Co LTD, China), and lidocaine (Beijing Yimin Pharmaceutical Co LTD, China).
Surgery of Plantar Incision
For the operation groups with plantar incision on the right hind paw, 136 rats were prepared as described by Brennan et al. 31 A 1 cm longitudinal incision was made with a number 11 blade, through skin and fascia of the plantar aspect of the foot, starting 0.5 cm from the proximal edge of the heel and extending toward the toes. Then the plantaris muscle was elevated and incised longitudinally. The muscle origin and insertion remained intact. After hemostasis with gentle pressure, the skin was apposed with 2 mattress sutures of 5 to 0 nylon.
Behavior Tests
Eighty rats were randomly assigned into 4 anesthesia groups with right hind paw incision: groups P (n = 20), R (n = 20), RL (n = 20), and L (n = 20). Cumulative pain score (40 rats, n = 10 for each group) and withdrawal response to von Frey filament application (40 rats, n = 10 for each group) were used to assess pain behavior as Brennan et al 31 described. For cumulative pain score, 40 unrestrained animals were placed in an elevated clear plastic cage with mesh floor after anesthesia. The incised foot was examined by using an angled magnifying mirror, and each animal was closely observed during a 1-minute period repeated every 5 minutes for 1 hour. Depending on the position in which the foot was found during the scoring period, a 0, 1, or 2 was given. If the foot bearing full weight without being blanched or distorted, a score of 0 was given; if the foot touching the floor but being blanched or distorted, a score All rats breathed spontaneously throughout anesthesia. Group L indicates propofol+lidocaine; Group P, propofol only; Group R, propofol+remifentanil; Group RL, propofol+remifentanil+lidocaine. of 1 was given; and if the foot being completely off the floor, a score of 2 was recorded. The sum of the 12 scores (0 to 24) obtained during the 1 hour session was used to assess pain in the incised foot. The animals were tested before anesthesia and at 30, 120, and 300 minutes postanesthesia.
Forty rats were placed in a clear plastic chamber (25 Â 25 Â 25 cm) with an elevated mesh floor waiting for recovery after drug cessation. Withdrawal responses to mechanical stimulation were determined using calibrated von Frey filaments applied from underneath the cage through openings in the mesh floor to the left side of wound and to the same area on the noninjured foot. Each von Frey filament was applied once starting with 19.6 mN and continuing until a withdrawal response occurred or 588 mN (the cutoff value) was reached. After a 10 minutes test-free period, each filament was again applied once beginning with 19.6 mN until a withdrawal response was elicited. This was repeated a third time 10 minutes later. The lowest force from the 3 tests producing a response was considered the withdrawal threshold. The cutoff value, 588 mN, was recorded even if there was no withdrawal response to this force. The animals were tested before anesthesia and at 30, 120, and 300 minutes postanesthesia.
Subcellular Fractionation Preparation and Western Blot Analysis
Two hundred and sixteen rats were randomly assigned to 9 groups: (1) control, rats without any treatment (naive, n = 24); (2) sham, 4 anesthesia subgroups without operation (n = 96); (3) operation, 4 anesthesia subgroups with right hind paw incision (n = 96). After drug administration, rats were killed immediately (n = 8), 30 minutes (n = 8), and 120 minutes (n = 8) postanesthesia. The spinal cord was quickly removed and placed into ice-cold artificial cerebral spinal fluid (in mM: NaCl 125, KCl 2.5, CaCl 2 2.0, NaHCO 3 26, NaH 2 PO 4 1.25, MgCl 2 1.0, glucose 5, pH 7.4) bubbling with air flow mixed with 95% O 2 and 5% CO 2 . The dorsal horn area of lumbosacral enlargement was identified as required. In the control and sham groups, both ipsilateral and contralateral dorsal horns were collected as one specimen, and labeled as control, group P-s, R-s, RL-s, and L-s. For the operation groups, ipsilateral, and contralateral dorsal horns to the operated side were collected and labeled as group P-i and P-c, R-i and R-c, RL-i and RL-c, and L-i and L-c respectively.
As our previous reports, 27, 32, 33 the frozen samples were rapidly thawed and homogenized at 41C in Buffer A (7.0 mL/mg tissue) [50 mM Tris-Cl, pH7.5, containing 2 mM DTT, 2 mM EDTA, 1 mM EGTA, 50 mM 4-(2-aminoethyl)-benzenesulfonylfluoride hydrochloride, 5 mg/mL each of leupeptin, aprotinin, pepstatin A and chymostatin, 50 mM KF, 50 mM okadaic acid, 5 mM sodium pyrophosphate].
Homogenates were centrifuged at 300,000g for 30 minutes at 41C to yield the supernatant as cytosolic fraction. Then the pellet fractions were resuspended in the same volume of Buffer A containing 0.5% Nonidet P-40 before being sonicated and centrifuged again. The particulate fractions (the resulting supernatants), together with the cytosolic fractions, were analyzed for cPKCg membrane translocation. Protein concentration was measured by using the BCA kit (Pierce Company).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis were carried out as previously reported. 27, 33 Briefly, 25 mg of total protein from cytosolic or particulate fractions was loaded per lane for SDS-PAGE (10% SDS gel). After electrophoresis and transferring of proteins onto nitrocellulose membrane (NC membrane, Schleicher and Schell), the NC membrane was blocked with 10% nonfat milk in Tris-Tween buffered saline (20 mM Tris-Cl, pH 7.5, containing 0.15 M NaCl and 0.05% Tween 20) for 1 hour. The membrane was incubated with primary rabbit polyclonal antibody against cPKCg (1:1000, Santa Cruz Biotechnology Inc). To verify equal loading of protein, the same NC membrane was reprobed with primary mouse monoclonal antibody against b-actin (SigmaAldrich Company). The horseradish peroxidase-conjugated goat antirabbit or antimouse IgG (Amersham) were used as second antibodies at a 1:3000 dilution for 1 hour incubation. The ECL kit (PerkinElmer Life Science) was used to detect the signals in x-ray film.
Immunofluorescence Stains
As previously described, 34, 35 16 rats from group P (n = 4), R (n = 4), RL (n = 4), and L (n = 4) without plantar incision were perfused through the left ventricle with 0.9% NaCl, followed by 4% paraformaldehyde at 120 minutes postanesthesia. The lumbar segment 4 to 5 (L 4-5 ) of spinal cord were postfixed in 4% paraformaldehyde for 24 hour, and then dehydrated in 20% sucrose solution until the segments sank to the bottom. The tissue was sectioned at 40 mm thickness and placed in ice-cold 10 mM phosphate buffered saline. To block the endogenous peroxidase activity, the slices were incubated with 3% H 2 O 2 for 10 minutes. The sections were further incubated with primary rabbit polyclonal antibody against cPKCg (1:800, Santa Cruz Biotechnology Inc) for 24 hour at 41C. Alternate sections were incubated without the primary antibody as negative control. The fluorescein isothiocyanate-labeled goat antirabbit IgG (Green color, SigmaAldrich Company) was used as secondary antibody at a 1:200 dilution for 3 hour in the dark. The fluorescent images were obtained under a laser scan confocal fluorescent microscope (Olympus FV1000, Japan).
Statistical Analysis
Quantitative analysis for immunoblotting was carried out after scanning the x-ray film with Gel Doc 2000 imaging system (Bio-Rad) as in our previous reports. 27, 36 To detect cPKCg membrane translocation, the ratio of cPKCg (band density in particulate/band densities in both particulate and cytosol) of control was normalized to 100%, and the other groups were expressed as a percentage of control. The values were presented as mean ± SE from 8 independent experiments. Statistical analysis was conducted by 1-way analysis of variance followed by all pair wise multiple comparison procedures using Bonferroni test. The cumulative pain scores and withdrawal thresholds were analyzed by Kruskal-Wallis test, and further multiple comparisons were performed by Dunnett's test. Significance was regarded as P<0.05.
RESULTS

Effect of Systemic Lidocaine on Remifentanilinduced Hyperalgesia in Plantar Incised Feet of Rats
As shown in Figure 1A , the cumulative pain scores of group R at 30, 120, and 300 minutes postanesthesia increased significantly when compared with group P (*P<0.05). Similarly, the mechanical withdrawal thresholds of both contralateral (Fig. 1B) and ipsilateral (Fig. 1C) plantar in group R were significantly lower than that of group P at 30, 120, and 300 minutes (except contralateral plantar) postanesthesia (*P<0.05). This remifentanil-induced hyperalgesia was inhibited by systemic administration of low-dose lidocaine ( # P<0.05, group RL vs. group R).
Effect of Systemic Lidocaine on Remifentanilinduced cPKCc Membrane Translocation in Spinal Dorsal Horn of Rats
When data were segregated by surgical procedure, with sham surgery: cPKCg membrane translocation in group R, but not in groups RL or L, increased significantly at immediate, 30 and 120 minutes postanesthesia when compared with control group (Figs. 2, 3 , P<0.05). In the operative groups, cPKCg membrane translocation in contralateral dorsal horn was higher in group R-c than control and groups P-c, RL-c, and L-c at immediate, 30 and 120 minutes postanesthesia (Figs. 2, 3 , P<0.05). The cPKCg membrane translocation in the ipsilateral dorsal horn was also higher in group R-i than control and the other groups (group P-i, RL-i, and L-i) at immediate, 30 and 120 minutes postanesthesia (Figs. 2,  3 , P<0.05). However, when data were segregated by principle treatment (ie, by anesthetic protocol), no significant differences in cPKCg membrane translocation were found among sham, contralateral, and ipsilateral dorsal horns of incision plantar within groups P, R, RL, and L. These results suggested that the increased cPKCg membrane translocation is remifentanil specific, and systemic lidocaine could inhibit this remifentanil-induced cPKCg membrane translocation in dorsal horn.
Determination of cPKCc Distribution in Spinal Cord of Rats
To determine the inhibition of lidocaine on remifentanil-induced cPKCg membrane transloction in spinal dorsal horn neurons, we further performed immunofluorescence in groups P, R, RL, and L without plantar incision at 120 minutes postanesthesia. As shown in Figures 4A1-A4 , the cPKCg immunoreactants were mainly concentrated in Laminea II of dorsal horn. The cPKCg immunoreactivity accumulated at the cellular margins in group R (Fig. 4B2) , but more diffusely distributed throughout the cytoplasm of dorsal horn neurons in groups P, RL, and L (Figs. 4B1, B3, B4 ). These results indicated that lidocaine could inhibit remifentanil-induced cPKCg membrane translocation in the neurons located in laminae II of dorsal horn of rats.
DISCUSSION
The mechanism underlying remifentanil-induced hyperalgesia and the inhibitive effect of lidocaine were studied via the plantar incision pain model, which has FIGURE 2. Typical Western blot results showed the changes in cPKCg membrane translocation in spinal dorsal horn of rats after anesthesia immediately (A), and at 30 minutes (B) and 120 minutes (C) postanesthesia. cPKCg and b-actin were detected both in cytosolic and particulate fractions at 80 and 42 kd, respectively. c indicates contralateral; C, naive animal as control; cPKCg, conventional protein kinase C gamma; i, ipsilateral; L, propofol+lidocaine; P, propofol only; R, propofol+remifentanil; RL, propofol+ remifentanil+lidocaine; s, sham.
FIGURE 3. Quantitative analysis of cPKCg membrane translocation in spinal dorsal horn of rats immediately (A), and at 30 minutes (B) and 120 minutes (C) postanesthesia. Two hundred and sixteen rats were randomly assigned to 9 groups: control (naive, n = 24), sham (4 anesthesia subgroups without operation, n = 96), and operation (4 anesthesia subgroups with right hind paw incision, n = 96). After drug administration, rats were killed immediately (n = 8), 30 (n = 8) and 120 minutes (n = 8) postanesthesia. Data were segregated by surgical procedure as sham, contralateral, and ipsilateral groups or P, R, RL, and L groups according to the anesthesia protocol. *P<0.05 versus control, #P<0.05 versus R group, and n = 8 for each group. L indicates propofol+lidocaine; P, propofol only; R, propofol+ remifentanil; RL, propofol+remifentanil+lidocaine.
similarities to the human postoperative pain state. 37 This model demonstrates reproducible, quantifiable mechanical hyperalgesia after the incision. 31, 37 The anesthetics and dosage used in this controlled study were based on clinical practice, with the dosage used in this study being equal to routine human dosage based on body surface area. The experimental formula from the FDA (Guidance for Industry and Reviewers: Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers) to convert rat dose to human equivalent dose in mg (mg)/kg was as follows: human equivalent dose = rat dose Â 0.16. The human equivalent dose calculated by this formula is shown in Table 3 and is similar to that used in clinical practice.
Both the cumulative pain score and the von Frey withdrawal threshold described by Brennan are related to mechanical hyperalgesia. 31 The results of behavioral tests in this study showed that the cumulative pain score was higher and the withdrawal threshold was lower in group R than in groups P and L. The results that indicate intraoperative infusion of remifentanil enhanced mechanical sensitivity are similar to those previously reported by Schmidt et al 38 in patients having ophthalmological surgery, and suggest that remifentanil-induced hyperalgesia is a general effect in the central nervous system. Further more, cumulative pain score in group RL was similar to groups P and L, but lower than group R. Withdrawal threshold in both ipsilateral and contralateral sides in group RL were higher than group R. These results indicate that low-dose lidocaine prevents hyperalgesia in propofol-remifentanil-based anesthesia.
As ultra-short-acting m-opioid receptor agonist, remifentanil is occasionally associated with acute opioid tolerance and postoperative hyperalgesia, but the involved mechanisms have remained unclear. Recent studies have confirmed that d-opioid receptors, not m-opioid receptors contribute to remifentanil-induced nociception 39 ; selective d-opioid receptor inhibition attenuates remifentanil-induced acute pain and tolerance to opioids 17 ; and remifentanil increases the activity of NMDA receptors through a m-opioid receptor-initiated signaling pathway. 20 PKC-mediated activation of NMDA receptors play an important role in the painfacilitating pathway, 40 and are involved in opioid-induced hyperalgesia. 21, 41, 42 Theses reports are consistent with our finding that systemic administration of remifentanil increased cPKCg membrane translocation (activation) in spinal dorsal horn during and after anesthesia.
Lidocaine has been shown to reduce postoperative and long-lasting neuropathic pain, [43] [44] [45] but the mechanisms are unknown. Previous reports have shown that local anesthetics seem to act on a broad range of targets, such as voltage-gated Na + channels, Ca 2+ , and K + channels, transient receptor potential vanilloid-1 (TRPV-1) and NMDA receptors. 45 Interestingly, an in vitro study in Xenopus laevis oocytes showed that systemic administration of lidocaine inhibited the activation of human NMDA receptors and the mechanism of action may be mediated by inhibition of PKC. 16 In this study, we used an in vivo model to test the validity of lidocaine in inhibiting remifentanil-induced hyperalgesia and found that lidocaine could inhibit remifentanilinduced enhancement of cPKCg membrane translocation. and B1: propofol only (P); A2 and B2: propofol+remifentanil (R); A3 and B3: propofol+remifentanil+lidocaine (RL); A4 and B4: propofol+lidocaine (L). Distribution of cPKCg positive neurons in spinal dorsal horn was shown in A1 to A4. cPKCg immunoreactivity accumulated at the cellular margins in group R (B2), but more diffusely distributed throughout the cytoplasm of laminea II neurons in groups P, RL, and L (B1, B3, and B4). Scale bar = 100 mm in images A1 to A4 and 30 mm in images B1 to B4. cPKCg indicates conventional protein kinase Cgamma.
In conclusion, this is the first study to combine lidocaine with propofol-remifentanil-based anesthesia. We found that increased cPKCg membrane translocation in spinal dorsal horn was involved in remifentanilinduced hyperalgesia, which could be inhibited by systemic administration of low-dose lidocaine and may contribute to reduced postoperative pain in rats after propofol-remifentanil-based anesthesia. 
